Sign in

CIK 0001650664

  • Non-accelerated filer
  • Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464097528
Phone
+1 617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market sale President and CEO sold 8,333 shares at an average $36.18 ($301,451)
  4. 4 Open-market sale President and CEO sold 20,000 shares at an average $38.79 ($775,860)
  5. 4 Open-market sale President and CEO sold 3,338 shares at $35.28 ($117,765)
  6. 4 Open-market sale President and CEO sold 14,995 shares at an average $34.15 ($512,053)
  7. 4 Open-market sale Chief Financial Officer sold 14,649 shares at an average $24.68 ($361,465)
  8. 4 Open-market sale President and CEO sold 8,333 shares at an average $29.58 ($246,522)
  9. 4 Open-market sale Chief Financial Officer sold 10,000 shares at an average $25.08 ($250,805)
  10. 4 Open-market sale President and CEO sold 8,333 shares at an average $23.64 ($196,966)
  11. 4 Open-market sale President and CEO sold 8,333 shares at an average $24.78 ($206,525)
  12. 4 Open-market sale President and CEO sold 16,666 shares at an average $20.33 ($338,831)
  13. 4 Other acquisition Director acquired 1,686 shares (other)
  14. 4 Open-market sale President and CEO sold 16,666 shares at an average $20.02 ($333,610)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 14 of 18 · 351 filings